One novel option to demonstrate and monitor post-treatment inflammatory reactions and the immunologic tumor microenvironment (TME) is dual-tracer PET imaging with 18F-FET and 18F-DPA-714 (a ligand of microglial translocator protein (TSPO)). The gene discussed is TSPO; the disease is neoplasm.